Element Six’s DNV-B1™ Announced Winner for the Quantum Category at the 13th Edition of the SPIE Prism Awards

First general-purpose quantum grade diamond enables users to unlock next generation quantum technologies. 

Element Six (E6), part of the De Beers Group, has been named as a Prism Awards winner in the quantum category for its chemical vapour deposition (CVD) quantum grade diamond, DNV-B1™, part of the DNV™ Series. 

The prestigious award, which is judged by a panel of industry experts and is part of the SPIE Photonics West yearly event programme, recognises leading industrial innovations that make a difference, solve problems, and improve life through optics and photonics across a range of different areas. Element Six’s DNV-B1™ was announced as the quantum category winner, ahead of fellow finalists Qnami, with their ProteusQ™, and AUREA Technology, with their Quantum Entangled Photon Source.

Launched in 2020, DNV-B1™ is Element Six’s first general-purpose CVD quantum grade diamond available on the market. Building on the company’s extensive experience, international network and a unique, patented process to develop bespoke CVD diamond solutions, DNV-B1™ is an ideal starting material for those interested in researching nitrogen-vacancy (NV) ensembles for quantum demonstrations, masers, detection of RF radiation, gyroscopes and magnetic sensing.

Diamond NV (DNV) centres offer researchers a unique solid-state platform with spin qubits that can be initialised and read out at room temperature, with long qubit lifetimes. Developed to provide a baseline solution that contains a uniform density of NV spin centres, Element Six’s DNV-B1™ was specifically designed for emerging diamond applications that require ensembles of NV centres, guaranteeing a minimum level of performance.

ProteusQ™, Qnami’s quantum microscope containing Element Six’s diamond was also a finalist in the quantum category. ProteusQ™ is the first desktop-scale diamond-enabled NV scanning microscope, made possible with bespoke quantum grade CVD diamond developed and engineered by Element Six. The microscope uses scanning NV magnetometry to enable table-top analysis of magnetic materials at the atomic scale, offering an unprecedented, miniaturised solution to processes that had previously relied on large-scale light sources.

Matthew Markham, Principal Scientist at Element Six, said: “It really is a honour to receive such a prestigious award and we are grateful to SPIE and its panel of experts for this recognition. We have been developing diamond-enabled quantum solutions for many years and it is rewarding to witness the transition from academic-led research to commercially-available solutions in a number of industrial applications. We are really proud of the DNV-B1™ and the technology it enables, from fundamental quantum physics to magnetic sensors.”

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Element Six. (2021, March 04). Element Six’s DNV-B1™ Announced Winner for the Quantum Category at the 13th Edition of the SPIE Prism Awards. AZoM. Retrieved on June 14, 2024 from https://www.azom.com/news.aspx?newsID=55693.

  • MLA

    Element Six. "Element Six’s DNV-B1™ Announced Winner for the Quantum Category at the 13th Edition of the SPIE Prism Awards". AZoM. 14 June 2024. <https://www.azom.com/news.aspx?newsID=55693>.

  • Chicago

    Element Six. "Element Six’s DNV-B1™ Announced Winner for the Quantum Category at the 13th Edition of the SPIE Prism Awards". AZoM. https://www.azom.com/news.aspx?newsID=55693. (accessed June 14, 2024).

  • Harvard

    Element Six. 2021. Element Six’s DNV-B1™ Announced Winner for the Quantum Category at the 13th Edition of the SPIE Prism Awards. AZoM, viewed 14 June 2024, https://www.azom.com/news.aspx?newsID=55693.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.